Clinical implications of pharmacogenomics for tardive dyskinesia

被引：0
|
作者：
D J Müller
T Shinkai
V De Luca
J L Kennedy
机构：
[1] Neurogenetics Section,Clarke Division, Department of Psychiatry
[2] University of Toronto,undefined
[3] Centre for Addiction and Mental Health,undefined
来源：
The Pharmacogenomics Journal | 2004年 / 4卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：77 / 87
页数：10
相关论文
共 50 条
  • [1] Clinical implications of pharmacogenomics for tardive dyskinesia
    Müller, DJ
    Shinkai, T
    De Luca, V
    Kennedy, JL
    [J]. PHARMACOGENOMICS JOURNAL, 2004, 4 (02): : 77 - 87
  • [2] TARDIVE-DYSKINESIA - PHARMACOLOGY AND CLINICAL IMPLICATIONS
    GOETZ, CG
    WEINER, WJ
    NAUSIEDA, PA
    KLAWANS, HL
    [J]. CLINICAL NEUROPHARMACOLOGY, 1982, 5 (01) : 3 - 22
  • [3] CLINICAL FACTORS IN TARDIVE-DYSKINESIA
    STRAKER, M
    [J]. PSYCHIATRIC JOURNAL OF THE UNIVERSITY OF OTTAWA-REVUE DE PSYCHIATRIE DE L UNIVERSITE D OTTAWA, 1980, 5 (01): : 28 - 33
  • [4] TARDIVE DYSKINESIA: CLINICAL PRESENTATION AND TREATMENT
    van Harten, Peter N.
    Tenback, Diederik E.
    [J]. PATHOPHYSIOLOGY, PHARMACOLOGY, AND BIOCHEMISTRY OF DYSKINESIA, 2011, 98 : 187 - 210
  • [5] Clinical characteristics of patients with tardive dyskinesia
    Held, T
    Weber, T
    Krausz, H
    Ahle, G
    Hager, B
    Alfter, D
    Schulze, T
    Knapp, M
    Maier, W
    Rietschel, M
    [J]. FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2000, 68 (07) : 321 - 331
  • [6] CLINICAL PROFILES OF TARDIVE-DYSKINESIA
    ITIL, TM
    REISBERG, B
    HUQUE, M
    MEHTA, D
    [J]. COMPREHENSIVE PSYCHIATRY, 1981, 22 (03) : 282 - 290
  • [7] PHARMACOLOGICAL PROBES OF NEUROTRANSMITTER SYSTEMS IN TARDIVE-DYSKINESIA - IMPLICATIONS FOR CLINICAL MANAGEMENT
    NASRALLAH, HA
    DUNNER, FJ
    MCCALLEYWHITTERS, M
    SMITH, RE
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 1986, 47 (02) : 56 - 59
  • [8] CLASSIFICATION OF NEUROLEPTICS - IMPLICATIONS FOR TARDIVE-DYSKINESIA
    CHRISTENSEN, AV
    [J]. POLISH JOURNAL OF PHARMACOLOGY AND PHARMACY, 1985, 37 (03): : 295 - 309
  • [9] Clinical risk factors for the development of tardive dyskinesia
    Solmi, Marco
    Pigato, Giorgio
    Kane, John M.
    Correll, Christoph U.
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2018, 389 : 21 - 27
  • [10] CLINICAL FORMS OF SEVERE TARDIVE-DYSKINESIA
    GARDOS, G
    COLE, JO
    SALOMON, M
    SCHNIEBOLK, S
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 1987, 144 (07): : 895 - 902
12345